| Literature DB >> 31281264 |
Carine de Freitas Souza1, Matheus Dellaméa Baldissera2, Bernardo Baldisserotto1, Berta Maria Heinzmann3, Juan Antonio Martos-Sitcha4, Juan Miguel Mancera4.
Abstract
In fish, stressful events initiate a hormone cascade along the hypothalamus-pituitary-interrenal and hypothalamus-sympathetic-chromaffin (HSC) axis to evoke several physiological reactions in order to orchestrate and maintain homeostasis. Several biotic and abiotic factors, as well as aquaculture procedures (handling, transport, or stocking density), activated stress system inducing negative effects on different physiological processes in fish (growth, reproduction, and immunity). In order to reduce these consequences, the use of essential oils (EOs) derived from plants has been the focus of aquaculture studies due to their diverse properties (e.g., anesthetic, antioxidant, and antimicrobial), which have been shown to reduce biochemical and endocrine alterations and, consequently, to improve the welfare status. Recently, several studies have shown that biogenic compounds isolated from different EOs present excellent biological activities, as well as the nanoencapsulated form of these EOs may potentiate their effects. Overall, EOs presented less side effects than synthetic compounds, but their stress-reducing efficacy is related to their chemical composition, concentration or chemotype used. In addition, their species-specific actions must be clearly established since they can act as stressors by themselves if their concentrations and chemotypes used are not suitable. For this reason, it is necessary to assess the effect of these natural compound mixtures in different fish species, from marine to freshwater, in order to find the ideal concentration range and the way for their administration to obtain the desired biological activity, without any undesired side effects. In this review, the main findings regarding the use of different EOs as stress reducers will be presented to highlight the most important issues related to their use to improve fish welfare in aquaculture.Entities:
Keywords: aquaculture; fish health; fish immundogy; fish stress; natural compounds
Year: 2019 PMID: 31281264 PMCID: PMC6596282 DOI: 10.3389/fphys.2019.00785
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Responses to stress in fish. The activation of the hypothalamus-sympathetic-chromaffin and hypothalamus-pituitary-interrenal axes culminates in the release of catecholamines and cortisol, respectively. These hormones induced several stress secondary responses (modified from Wendelaar Bonga, 1997). (+) indicates activation and/or increase and (−) indicates inhibition and/or reduction.
The use of essential oils (EOs) as stress-reducing agents in fish exposed to handling and air exposure.
| Geranial (28.97) | Air exposure/1 min | Anesthesia/300 μL⋅L–1 | Prevents increase in plasma cortisol levels | |||
| β-citral (20.78) | Handling | Diet supplemented with 2.0 mL per kg | Reduces plasmatic cortisol and lactate levels | |||
| 1.8 cineole (80.84%) | Handling | Anesthesia/300 μL⋅L–1 | Induces a stress response after 24 h of exposure, inducing plasma cortisol enhancement and up regulation of | |||
| Linalool (55.26%) | Air exposure/1 min | Anesthesia and stress-reducing agent/100–500 mg⋅L–1 | Reduces plasma cortisol levels | |||
| β-linalool (50.56%) | Anesthesia/100–300 μL⋅L–1 | Decreases TBARS and protein carbonyl levels in liver and kidney | ||||
| Linalool (54.38%) | Handling and air exposure/1 min | Anesthesia/300 and 450 μL⋅L–1 | Prevents Na+-K+-ATPase activity reduction due to handling. | |||
| β-linalool (50.56%) | Anesthesia/100–300 μL⋅L–1 | Decreases | ||||
| β-linalool (87.6%) | Persecution/1 min | Stress-reducing agent/ 35 μL⋅L–1 | Increases | |||
| E-citral (29.84%) | Air exposure/1 min | Anesthesia/300 μL⋅L–1 | Enhances protein carbonyl levels in liver and kidney | |||
| Increases s | ||||||
| Geranial (25.4%) | Rapid air exposure for biometry | Sedation and stress-reducing agent/50 and 100 μL⋅L–1 | Increases plasma glucose and ammonia values. | |||
| Pulegone (95.17%) | Handling and air exposure/1 min | Anesthesia/300 and 450 μL⋅L–1 | Prevents Na+-K+-ATPase activity reduction caused by handling. | |||
| Carvone (28.4%) | Handling | Anesthesia/5 mL L–1 | Reduces opercular rate and decreases plasma glucose levels after recovery | |||
| Eugenol (43.3%) | Handling/fish transfer from cage to buckets and then back to cage | Anesthesia and stress-reducing agent/20–60 mg⋅L–1 | Increases plasma glucose and lactate/ammonia values only at 60 mg⋅L–1 | |||
| Eugenol (73.6%) | Handling | Anesthesia/70 and 300 mg⋅L–1 | Enhances plasma glucose levels | |||
| 1,8-cineole (21.0%) | Air exposure/1 min | Anesthesia/300 and 500 mg⋅L–1 | Prevents plasma cortisol increase and Na+ loss | |||
| Carvacrol (78.16%) | Handling | Anesthesia/50 μL⋅L–1 | Decreases stress-related genes ( | |||
| Eugenol | Handling | Anesthesia/700 mg⋅L–1 | Increased plasma cortisol and glucose levels | |||
| Handling | Anesthesia/50 mg⋅L–1 | Decrease plasma cortisol and glucose levels | ||||
| Handling | Anesthesia/50–200 μL⋅L–1 | Does not prevent plasma cortisol increase caused by handling |
FIGURE 2Effects of essential oils (EOs) on physiological changes induced by aquaculture procedures, handling, transport, and diseases. (+) indicates activation and/or increase and (−) indicates inhibition and/or reduction.
The use of essential oils (EOs) as stress-reducing agents in fish transport.
| NA | Transport in plastic bags/7 h | Anesthetic/90 mg⋅L–1 | Increases plasma glucose values and mortality | |||
| E-citral (42.30) | Transport/4 h | Sedation/40 and 50 μL⋅L–1 | Reduces ammonia excretion and plasma cortisol levels | |||
| α-citral (20.41) | Transport/4 h | Sedative and stress-reducing agent/25 μL⋅L–1 | Decreases total ammonia nitrogen levels and ventilatory frequency. | |||
| β-selinene (9.96) | Transport simulation/360 min | Sedation/40 μL⋅L–1 | Reduces plasma cortisol levels and preventing a stress response as well as excess of reactive oxygen species formation. | |||
| Linalool* | Transport/5, 6, 7 h | Slight sedation/10–20 μ⋅L–1 | Improves redox state | |||
| Transport/4 h | Stress- reducing agent/1.5 and 3.0 μL⋅L–1 | Reduces net Na+, Cl | ||||
| Transport/6 h | Sedation/30–40 μL–1 | Induces oxidative stress | ||||
| Linalool (47.66) | Tambacu ( | Transport (8 h) and handling (0, 1 and 4 h) | Stress- reducing agent and anesthesia/10–200 μL⋅L–1 | Prevents plasma cortisol levels enhancement | ||
| Simulated transport/4 h | Anesthetic/12 mg⋅L–1 | Increases plasma cortisol values | ||||
| β-phellandrene (31.48) | Transport simulation/6 h | Sedation/10 μL⋅L–1 | Decreases plasma cortisol levels as well as prevents stress response and excess of reactive oxygen species formation | |||
| β-phellandrene (31.48) | Pre-transport handling/transport (6 h) | Stress-reducing agent | Reduces plasma cortisol and lactate levels as well as increases | |||
| NA | Transport/2, 6, and 10 h | Sedation and stress-reducing agent/30 μL⋅L–1 | Enhances protection against oxidative damage mainly in muscle and gills | |||
| bicyclogermacrene (34.6) | Transport/10 h | Stress-reducing agent/30 and 300 μL⋅L–1 | Increases plasma glucose and lactate levels. | |||
| Eugenol | Transport simulation/3.5 h | Sedation/20 μL⋅L–1 | Decrease plasma cortisol and glucose levels | |||
| 3 mg⋅L–1 | Increase in plasmatic cortisol levels | |||||
| and 1 mg⋅L–1 | Decrease plasmatic cortisol levels | |||||
| Transport simulation/6 h | Sedation/2.5 mg⋅L–1 | Increase in plasmatic cortisol levels and expression of |
The use of essential oils (EOs) as stress-reducing agents in fish diseases.
| β-citral (20.78) | Infection by | Diet supplemented/2.0 mL per kg diet | Improves survival and decreases the total count of leukocytes, lymphocytes, and neutrophils | |||
| Limonene (54.4) | Infection by | Diet supplemented/0.5, 0.75, and 1% | Enhances non-specific immune parameters and decrease mortality rate | |||
| Pulegone (96.63) | Infection by | Preventive baths/20 mg⋅L–1 | Increases survival | |||
| Terpinen-4-ol (27.15) | Infection by | Preventive baths/50 μL⋅L–1 | Increases the non-specific immune system and prevents oxidative damage | |||
| Preventive baths/50 μL⋅L–1 | Prevents alterations to purinergic enzymes and ameliorates the innate immune response. | |||||
| Terpinen-4-ol (41.98) | Infection by | Preventive baths/50 μL⋅L–1 | Ameliorates the hepatic antioxidant/oxidant status | |||
| 1,8-cineole (40.4) | Infection by | Diet supplemented during 55 days/0.5, 1.0, and 1.5% | Improves growth, immune responses and disease resistance | |||
| β-linalool (46.6) | Infection by | Preventive baths/20 mg⋅L–1 | Increases survival | |||
| NA | Low temperature and challenge by | Diet supplemented/30 and 60 mg⋅L–1 | Enhances immune system | |||
| Geranial (24.0) | Infection by | Diet supplemented during 55 days/0.5 and 1.0% | Improves immune responses and disease resistance | |||
| Eugenol | Infection by | Baths (5 and 10 mg⋅L–1) | Promoted the survival but did not change phagocytic activity, production of superoxide anion, serum hemolytic activity, and hematology. |